632 followers
Biosafety and biohazard considerations of HSV-1-based oncolytic viral immunotherapy https://t.co/PUUWOxkpXU
Biosafety and biohazard considerations of HSV-1-based oncolytic viral immunotherapy https://t.co/PUUWOxkpXU
New Research: Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy #MolBioSci https://t.co/jywXIJT0uI